Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.

Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.

OBJECTIVES: To determine the prevalence, determinants ofpositivity, and clinical utility of serum cryptococcal polysaccharide (CPS) antigen testing among HIV-infected patients in 2004 in Cambodia, an area highly endemic for cryptococcosis. METHODS: All HIV-infected patients with a CD4+ count &l...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Micol, R, Lortholary, O, Sar, B, Laureillard, D, Ngeth, C, Dousset, J, Chanroeun, H, Ferradini, L, Guerin, P, Dromer, F, Fontanet, A
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2007

Παρόμοια τεκμήρια

Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007).
ανά: Micol, R, κ.ά.
Έκδοση: (2009)

Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era.
ανά: Caroline Charlier, κ.ά.
Έκδοση: (2008-01-01)

Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.
ανά: Rachel M Smith, κ.ά.
Έκδοση: (2013-01-01)

Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia
ανά: Miaomiao Xu, κ.ά.
Έκδοση: (2020-04-01)

Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand
ανά: Candice K. Kwan MD, κ.ά.
Έκδοση: (2014-09-01)

Asymptomatic cryptococcal antigenemia is associated with mortality among HIV‐positive patients in Indonesia
ανά: Ahmad Rizal Ganiem, κ.ά.
Έκδοση: (2014-01-01)

High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia.
ανά: Abere Shiferaw Alemu, κ.ά.
Έκδοση: (2013-01-01)

Cryptococcal antigenemia and susceptibility of Cryptococcuss neoformans to antifungal agents in HIV infection
ανά: A.O. Atayese, κ.ά.
Έκδοση: (2020-12-01)

Epidemiology of Cryptococcal antigenemia among HIV infected patients in southwestern Nigeria
ανά: Odekunle Bola Odegbemi, κ.ά.
Έκδοση: (2019-10-01)

Opportunistic Cryptococcal Antigenemia in the HAART Era at HIV Epidemic Settings of Northwest Ethiopia
ανά: Markos Negash, κ.ά.
Έκδοση: (2020-01-01)

Asymptomatic cryptococcal antigenemia in HIV-infected patients: a review of recent studies
ανά: Xiao-Lei Xu, κ.ά.
Έκδοση: (2020-12-01)

Epidemiology of Cryptococcal antigenemia among HIV infected patients in South-western Nigeria
ανά: O. Odegbemi, κ.ά.
Έκδοση: (2020-12-01)

Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV‐positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania
ανά: Kinanga A Magambo, κ.ά.
Έκδοση: (2014-01-01)

Prevalence of Cryptococcal Antigenemia and Lateral Flow Assay Accuracy in Severely Immunosuppressed AIDS Patients
ανά: Adriana Carla Garcia Negri, κ.ά.
Έκδοση: (2024-07-01)

A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria
ανά: Rita O. Oladele, κ.ά.
Έκδοση: (2023-01-01)

A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria.
ανά: Rita O Oladele, κ.ά.
Έκδοση: (2023-01-01)

{'en_US': 'Sero-prevalance of Cryptococcal Antigenemia in HIV Positive Individual having CD4 Counts <100 Cells/mm3'}
ανά: Sundar Khadka, κ.ά.
Έκδοση: (2021-12-01)

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts
ανά: Martha P. Montgomery, κ.ά.
Έκδοση: (2017-06-01)

Prevalence of Cryptococcal Antigenemia and Associated Factors among HIV/AIDS Patients at Felege-Hiwot Referral Hospital, Bahir Dar, Northwest Ethiopia
ανά: Mohabaw Jemal, κ.ά.
Έκδοση: (2021-01-01)

Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review
ανά: Awoke Derbie, κ.ά.
Έκδοση: (2020-06-01)

Cryptococcal Antigenemia in Anti-Retroviral Naïve AIDS Patients: Prevalence and Its Association with CD4 Cell Count
ανά: Oghomwen Favour Osazuwa, κ.ά.
Έκδοση: (2012-05-01)

Cryptococcal Antigenemia in Anti-Retroviral Naïve AIDS Patients: Prevalence and Its Association with CD4 Cell Count
ανά: Evbaguehita Okuonghae, κ.ά.
Έκδοση: (2012-05-01)

Prevalence of Cryptococcal Antigenemia and associated factors among HIV/AIDS patients on second-line antiretroviral therapy at two hospitals in Western Oromia, Ethiopia.
ανά: Nuguse Geda, κ.ά.
Έκδοση: (2019-01-01)

Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3
ανά: James Wykowski, κ.ά.
Έκδοση: (2020-01-01)

CRYPTOCOCCAL ANTIGENEMIA IN HIV/AIDS PATIENTS USING LATERAL FLOW IMMUNOASSAY DETECTION AT Dr. SOETOMO GENERAL HOSPITAL SURABAYA
ανά: Sajuni Widjaja, κ.ά.
Έκδοση: (2018-03-01)

No association of cryptococcal antigenemia with poor outcomes among antiretroviral therapy-experienced HIV-infected patients in Addis Ababa, Ethiopia.
ανά: Christopher C Smitson, κ.ά.
Έκδοση: (2014-01-01)

Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia.
ανά: Romain Micol, κ.ά.
Έκδοση: (2010-11-01)

Prevalence and Associated Factors of Cryptococcal Antigenemia in HIV-Infected Patients with CD4 < 200 Cells/µL in São Paulo, Brazil: A Bayesian Analysis
ανά: Evanthia Vetos Mimicos, κ.ά.
Έκδοση: (2022-12-01)

Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda.
ανά: Elissa K Butler, κ.ά.
Έκδοση: (2012-01-01)

High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique.
ανά: Robert Deiss, κ.ά.
Έκδοση: (2021-01-01)

Correction: High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique.
ανά: Robert Deiss, κ.ά.
Έκδοση: (2024-01-01)

Correction: High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique
Έκδοση: (2024-01-01)

Six months survival and risk factors for attrition for patients detected with cryptococcal antigenemia through screening in Malawi.
ανά: Master R O Chisale, κ.ά.
Έκδοση: (2023-01-01)

Cryptococcal antigenemia screening among human immunodeficiency virus-infected cases with tuberculosis: Chance and cost effectiveness
ανά: Sora Yasri, κ.ά.
Έκδοση: (2018-01-01)

Screening for cryptococcal antigenemia and meningeal cryptococcosis, genetic characterization of Cryptococcus neoformans in asymptomatic patients with advanced HIV disease in Kinshasa, Democratic Republic of Congo
ανά: Bive Bive Zono, κ.ά.
Έκδοση: (2024-12-01)

Cryptococcal antigenemia and associated risk factors among ART‐naïve and ART‐experienced HIV‐infected peoples at selected health institutions of Mekelle, Northern Ethiopia
ανά: Kibra Hailu, κ.ά.
Έκδοση: (2019-06-01)

Molecular epidemiology of Group A Streptococcus infections in Cambodian children, 2007-2012.
ανά: Turner, P, κ.ά.
Έκδοση: (2015)

Cryptococcal meningitis: a neglected NTD?
ανά: Molloy, S, κ.ά.
Έκδοση: (2017)

Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa.
ανά: Bruce A Larson, κ.ά.
Έκδοση: (2016-01-01)

High prevalence of antimicrobial resistant Gram negative colonization in hospitalized Cambodian infants
ανά: Turner, P, κ.ά.
Έκδοση: (2016)